-transparent.png){kind=logo}
BACKGROUND Specific immunotherapy (SIT) represents the only specific treatment that can be offered to allergic patients apart from allergen avoidance. SIT has been widely used in pollen allergic rhinitis. Clinical efficacy has been demonstrated in several controlled clinical trials and depends on the specific allergen the individual patient is sensitive to, the quality and total amount of allergen applied, and the SIT schedule. In classic SIT, gradually increasing dosages of the allergen extract are injected subcutaneously. Several dosage schedules for subcutaneous SIT can be applied. In Cluster-SIT, 2 - 3 injections per day of treatment are given once a week during induction treatment. METHODS In this study, we investigated 64 patients (33 female, 31 male) from 18 to 54 years (26.9 +/- 5.1 years) in terms of side-effects of Cluster-SIT during induction treatment. RESULTS The total amount of enlarged local reactions (> grade 1) was n = 77 or 15.2 % of all injections. Of these, 68 (88 %) were classified as immediate reactions, 8 (11 %) were late phase reactions and 1 (1 %) was immediate as well as late phase reaction. Of all enlarged local reactions, 48 (62 %) were grade 1 reactions, 13 (17 %) were grade 2 reactions, 13 (17 %) were grade 3 reactions and 1 (1 %) was a grade 4 reaction. The total amount of systemic reactions was n = 22 or 4.3 % of all injections. Of these, 19 (86 %) were classified as immediate reactions, 3 (14 %) were delayed reactions. Of all systemic reactions, 18 (82 %) were grade 1 reactions and 4 (18 %) grade 2 reactions. Grade 3 or grade 4 reactions did not occur. There were no differences in gender or age regarding the occurrence of side effects (all p > 0.05). CONCLUSIONS Frequency and severity of adverse side effects in Cluster-SIT correspond to those in other dosage schedules. On behalf of security aspects, Cluster-SIT could become an interesting alternative dosage schedule for dose increase during SIT. Furthermore, in Cluster-SIT with allergoids, induction treatment can be carried out in two treatment days of approximately 2.5 hours each.
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
February 2010,
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
November 2009,
HNO,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
January 2023,
Cells,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
March 2008,
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
February 2007,
Pediatrics international : official journal of the Japan Pediatric Society,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
January 2007,
The Cochrane database of systematic reviews,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
October 1983,
The Journal of allergy and clinical immunology,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
May 2024,
Allergy,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
February 2010,
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
I Hansen, and
K Hörmann, and
B A Stuck, and
S Schneider-Gêne, and
R Mösges, and
L Klimek
January 2021,
Frontiers in medicine,
